AEON Biopharma Inc. (AEON)
undefined
undefined%
At close: undefined
0.21
-1.79%
Pre-market Jan 08, 2025, 06:03 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY22 FY21 FY20 FY19
Revenue n/a n/a 2.52M 3.36M
Cost of Revenue n/a n/a n/a 1K
Gross Profit n/a n/a 2.52M 3.36M
Operating Income -48.43M -65.85M -16.39M -53.97M
Interest Income n/a n/a n/a 720.00K
Pretax Income -52.56M -55.64M -32.91M 145.67M
Net Income -52.56M -55.64M -32.91M 172.92M
Selling & General & Admin 13.68M 11.15M 11.59M 46.04M
Research & Development 34.75M 25.73M 7.32M 4.81M
Other Expenses n/a 10.21M -5.61M -10.75M
Operating Expenses 48.43M 36.88M 18.91M 51.73M
Interest Expense n/a n/a 15.00K 7.47M
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 48.43M 36.88M 18.91M 51.73M
Income Tax -160.49K 28.97M 15.00K -14.64M
Shares Outstanding (Basic) n/a 22.00M 14.80M 14.80M
Shares Outstanding (Diluted) n/a 22.00M 14.80M 14.80M
EPS (Basic) n/a -2.53 -2.22 11.69
EPS (Diluted) n/a -2.53 -2.22 11.69
EBITDA -48.36M -7.91M -22.14M -50.41M
Depreciation & Amortization 68.00K 3.00K -5.75M 1.26M